Condition

Poly Cystic Ovary Syndrome clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Poly Cystic Ovary Syndrome clinical trials that are recruiting, at sites in 2 countries (most in Egypt (2), United States (1)). By phase: Phase 3 (1), Phase 1 (1), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Poly Cystic Ovary Syndrome clinical trials

StudyPhaseWhereStatusRegistered
See if exemestane helps PMOS patients ovulate compared with placebo Phase 1 Raleigh, North Carolina Recruiting Jul 15, 2026
Alpha-lipoic acid and myo-inositol for non-diabetic PCOS in women Phase 3 Cairo, Cairo Governorate Recruiting Jun 5, 2026
Comparing Vildagliptin and Metformin for treating Polycystic Ovary Syndrome Phase 2/3 Giza Recruiting Nov 21, 2023

All recruiting trials (3)

Quick answers

How many Poly Cystic Ovary Syndrome clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in Egypt (2 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1, Phase 1: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.